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Abstract: The ocular pathology of autoimmune retinopathy is demonstrated in a 62-year-old female patient with systemic 
lupus erythematosus (SLE) who presented with typical clinical autoimmune retinopathy. Macroscopically, there were 
multiple depigmented lesions in the peripheral retina and choroid and scattered pigmentary bone-spickling at the equator 
and periphery. Microscopically, there were generalized loss of photoreceptors and thinning of the outer plexiform layer. 
Many peripheral retinal vessels were sclerotic and occluded, some surrounded by pigment granules and RPE cells. 
Cobblestone degeneration was prominent in the periphery. Macrophages were seen in the retina, particularly in areas of 
photoreceptor degeneration. Rare, scattered T- lymphocytes were present in the retina and choroid, while B-cells were 
notably absent. The optic nerve showed loss of axons and thickened septae. Serum autoantibodies against normal retinal 
nuclei were detected. These pathological changes represent both known SLE-associated ocular complications as well as 
possible features of autoimmune retinopathy secondary to SLE. 
INTRODUCTION 
  Systemic lupus erythematosus (SLE) is an autoimmune 
disorder characterized by abnormal deposition of circulatory 
immune complexes in blood vessel walls. The deposition 
causes inflammation through activation of the complement 
system, resulting in tissue damage and disease mani-
festations [1]. The disease affects mainly the joints, skin, 
kidneys and cardiopulmonary system. However, other 
organs, such as the liver, spleen, brain and eyes may be 
involved as well [2]. Autoantibodies produced by the 
cooperation of B and CD4 T-cells are a central feature of 
SLE. Ocular complications of SLE are well documented, 
including keratoconjunctivitis sicca, retinal vascular disease 
with vasculitis and vascular occlusion, choriodopathy, and 
optic neuritis [1, 3]. 
  Autoimmune retinopathy (AIR) is an immunological 
process whereby retinal autoantibodies attack the retina 
tissue, resulting in retinal degeneration and eventual 
blindness [4]. Three main subtypes of AIR have been identi-
fied: cancer-associated retinopathy (CAR), melanoma-
associated retinopathy (MAR), and, less commonly, non-
neoplastic autoimmune retinopathy (npAIR). In addition, 
AIR is hypothesized to play a role in retinitis pigmentosa, 
ocular trauma, birdshot retinopathy, acute zonal occult outer 
retinopathy (AZOOR), and multiple evanescent white dot 
syndrome (MEWDS) [4]. Reports of the ocular histopatho-
logic changes in AIR are limited. Herein we describe the 
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CASE 
  The study was approved by the National Eye Institute 
Institutional Review Board for human subjects, and informed 
consent was obtained from the patient. The case involves a 
62-year-old white female with SLE who died of progressive 
multifocal leukoencephalopathy caused by JC virus within 
the central nervous system. She was on hydroxychloroquine 
(Plaquenil) for SLE for 8 years. Laboratory analysis revealed 
the following positive serum antibodies: antinuclear antibody 
(ANA), Smith (Sm, a nuclear ribonucleoprotein that is 
specific to SLE), ribonucleoprotein (RNP, nuclear or 
cytoplasmic), as well as positive lupus anticoagulant. The 
serum tested negative for -2-glycoprotein-1 (-2-GP1, the 
main affecter of cardiolipin binding) and anticardiolipin 
antibody (ACA). Two weeks prior to her death, the patient’s 
behavior suggested that she had experienced visual decline. 
Ocular testing revealed a best-corrected visual acuity of 
20/50 OD and 20/100 OS, color vision by Ishihara plates of 
13/16 OD and 11/16 OS, and contrast sensitivity in log units 
of 1.35 OD and 1.05 OS. Intraocular pressure was 17mmHg 
OD and 14mmHg OS. Posterior subcapsular cataracts were 
noted bilaterally. Fundus examination revealed a blunted 
foveal light reflex, peripheral “punched out” retinal lesions, 
and bone spickling bilaterally (Fig. 1). The patient was too ill 
to perform electrophysiological testing in clinic. A clinical 
diagnosis of AIR secondary to SLE was suspected. The 
patient’s eyes were obtained for autopsy. 
  Routine histopathology and immunohistochemistry were 
performed on both globes. Immunohistochemistry was conducted 
using the avidin-biotin-complex immunoperoxidase tech-
nique with the Betazoid DAB Chromogen Kit (Biocare 
medical, CA, USA). Primary antibodies included CD68 
(macrophage and microglia), CD3 (T-lymphocyte), and 
CD20 (B-lymphocyte) (Dako North America, Inc., 
Carpinteria, CA, USA). Secondary antibody was biotinylated Autoimmune Retinopathy in Systemic Lupus Erythematosus  The Open Ophthalmology Journal, 2009, Volume 3    21 
goat anti-mouse IgG (1: 200; Vector Laboratories, CA, 
USA). Confocal immunofluorescence was performed to 
detect autoantibodies in the patient’s serum, as described 
previously [5]. The technique in brief was as follows: normal 
human retinal sections were incubated with patient’s serum 
(1: 100), normal human serum (1: 100), or no serum, and 
then incubated with fluorescent secondary antibody (Alexa 
Fluor® 568 goat anti-human IgG (H+L), Invitrogen, USA). 
Immunoreactivity of each slide was assessed under a 
confocal microscope with the same confocal settings (Leica, 
Wetzlar, Germany). The images have been normalized to 
background fluorescence prior to visual comparisons. 
  Macroscopically, there were multiple pigmentary bone-
spickling lesions in the equator and peripheral retina of both 
eyes. Multiple medium- to large-sized focal depigmentary 
cobblestone lesions were also observed in the periphery (Fig. 
2). The optic nerve heads were pale. Microscopically, the  
 
lenses had posterior epithelial migration and posterior 
subcapsular globulins. The outer layers of the retina were 
diffusely atrophic and characterized by generalized loss of 
photoreceptors and thinning of the outer plexiform layer, 
sparing the temporal macula from the fovea to the equator of 
the right eye, but involving the entire macula of the left eye 
(Fig. 3). In the periphery, many retinal vessels were sclerotic 
and occluded in both eyes (Fig. 4). Some of the occluded 
vessels were surrounded by pigment granules and a few 
migrated RPE cells. Typical cobblestone degeneration was 
found in the temporal and peripheral retina of both eyes, 
characterized by an absence of choriocapillaris, RPE, 
photoreceptors and the outer nuclear layer, while the 
remaining inner nuclear layer was adherent to an irregular 
Bruch’s membrane. Hypertrophic RPE was present at the 
margin of these lesions. Macrophages and microglia were 
prominent in the retina where photoreceptors had been lost 
(Fig. 5A, D), as well as in the choroid. Rare T-lymphocytes 
 
Fig. (1). Fundus photographs. The color funduscopy of the right eye (R) and left eye (L) show blunted foveal light reflex, peripheral 
“punched out” lesions (white arrows) and bone spickling lesions (black arrows) bilaterally. 
 
Fig. (2). Macroscopic photograph. There are multiple pigmentary bone-spickling lesions (black arrows) in the equator and peripheral retina 
of both eyes (R, Right eye; L, Left eye). Multiple medium- to large-sized focal depigmentary cobblestone lesions (white arrows) are also 
observed in the periphery. 22    The Open Ophthalmology Journal, 2009, Volume 3  Cao et al. 
were scattered throughout the retina and choroid in both eyes 
(Fig.  5B,  E). Interestingly, there was no B-lymphocytic 
infiltration (Fig. 5C, F). The optic nerves demonstrated loss 
of axons and thickened septae, as well as mild to moderate 
macrophage infiltration and microglial accumulation. 
Positive immunoreactivity of patient’s serum was detected in 
the ganglion cell layer, as well as both inner and outer 
nuclear layers; in contrast, immunoreactivity was negative 
for control normal serum, which indicated the presence of 
serum autoantibodies against retinal cellular nuclei including 





Fig. (3). Microscopic macula. The retina is markedly atrophic characterized by generalized loss of photoreceptors and thinning of the outer 
plexiform layer except the temporal maculae from fovea to equator of the right eye (A, nasal; B, temporal), but worse in the left eye, even at 




Fig. (4). Microscopic retinas. A, some small retinal vessels are sclerotic (arrowheads) in the right eye. B, some occluded vessels (arrows) are 
surrounded by pigment granules and a few migrated RPE cells (arrowheads) in the right eye. C, The left eye shows an absence of 
choriocapillaris, RPE, photoreceptors and the outer nuclear layer, while the remaining inner nuclear layer was adherent to an irregular 
Bruch’s membrane. Hypertrophic RPE (arrows) was present at the margin of these lesions. (GCL, ganglion cell layer; INL, inner nuclear 
layer; ONL, outer nuclear layer; scale bar indicates 50 μm). Autoimmune Retinopathy in Systemic Lupus Erythematosus  The Open Ophthalmology Journal, 2009, Volume 3    23 
DISCUSSION 
  SLE is a chronic inflammatory disease of unknown 
origin with the ability to affect many organs. In a study of 
550 patients with SLE, Stafford-Brady and colleagues 
observed retinopathy in 41 patients (7.1%) [6], while a study 
of children with SLE reported ocular involvement in 35% of 
patients [7]. In the case of our patient, histopathologic 
examination of the peripheral retina revealed many small 
occluded vessels, some appearing similar to changes seen in 
chronic retinal vasculitis [8]. The vascular occlusive findings 
and cobblestone degeneration are likely the consequence of 
SLE vasculopathy and lupus anticoagulant thrombosis. 
  Histopathology of our patient’s eyes demonstrates diffuse 
loss of photoreceptors, including areas exhibiting normal 
retinal and choroidal vasculature. This finding suggests that 
the retinal abnormalities may not result from the common 
ocular complication of vascular inflammation and occlusion. 
Since SLE is associated with loss of B-cell tolerance, B-cell 
dysregulation, and high-affinity autoantibody production [9], 
the clinical and pathological presentation of our patient 
suggests that AIR could result from severe SLE. Although 
her serum demonstrated immunoreactivity not only against 
photoreceptor, but also other retinal cell nuclei, which may 
relate to elevated serum ANA; we could not rule out the 
presence of specific autoantibody targeting the photoreceptor 
in this case. 
  Antibodies against retinal antigens have been reported in 
patients with cancer, multiple sclerosis, and presumed in 
SLE, although AIR per se has not been documented in SLE 
patients [10-12]. The autoantibody response in SLE is both 
diverse and exuberant, targeting a variety of nucleoprotein 
particles, some containing DNA (nucleosomes), and others 
RNA. The latter include small nuclear ribonucleoproteins 
(RNPs), cytoplasmic RNPs, and ribosomes. Antibodies are 
also directed against negatively charged phospholipids. A 
striking feature of the different autoantigens in lupus is their 
lack of restriction to a single subcellular location. Since the 
retina develops embryologically as an extension of the neural 
tube, it shares with the neural tissue several cell membranes- 
and cytoplasm-associated antigens. It would seem possible, 
therefore, that patients with SLE could produce auto-
antibodies targeting neural-specific antigens, inducing neural 
tissue damage such as that seen in the retina of our patient 
[12-14]. We would therefore suggest our patient’s condition 
as npAIR. 
  Our patient was treated with Plaquenil, which has the 
potential to induce a toxic retinopathy [15] in a distinctive 
macular pattern not seen in our patient. She was also 
diagnosed with progressive multifocal leukoencephalopathy, 
a demyelinating brain disease caused by the JC papovavirus. 
This infection usually progresses rapidly, causing a variety 
of visual and neurologic complications. However, no 
association between progressive multifocal leukoencephalo-
pathy and AIR has been published in the literature. 
  The clinical spectrum of AIR is heterogeneous and 
diverse. The fundus may appear normal or demonstrate 
characteristics of retinal degeneration such as attenuated 
retinal vessels, waxy disc pallor, and RPE mottling or 
atrophy [4]. Signs of inflammatory activity are classically 
absent [16]. The primary features that suggest an auto-
immune component are the negative waveform on ERG [17] 
 
Fig. (5). Imunoreactivities against CD68, CD3, and CD20 markers in the retinas. A, CD68, right eye; B, CD3, right eye; C, CD20, right eye; 
D, CD68, left eye; E, CD3, left eye; F, CD20, left eye. CD68 positive cells are scattered in the retina, while most are where photoreceptor are 
lost. Rare, scattered CD3 positive cells are present in the retina. CD20 staining is negative in both eyes (Green = methyl green counterstain; 
brown = positive immunostain). (GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; Scale bar indicates 50 μm). 24    The Open Ophthalmology Journal, 2009, Volume 3  Cao et al. 
and visual field loss or scotomata [13]. The diagnosis is 
based in part on the detection of serum antiretinal antibodies 
in the setting of clinical and electrophysiological evidence of 
retinal degeneration [14, 18, 19]. If serum antibodies are 
identified against retinal tissue, and clinical symptoms and 
findings are compatible with retinal degeneration; a tentative 
diagnosis of AIR can be made. The hallmark of AIR is the 
subacute onset of symptoms, rapid progression of vision 
loss, and an abnormal ERG in a patient with an appropriate 
medical history. 
  AIR is associated with circulating antibodies directed 
against retinal proteins/antigens; however, the precise 
pathogenesis of AIR is still unknown. In AIR, the 
inflammation is usually minimal. In CAR, the targeted 
antigen is recoverin, a calcium-binding protein found in both 
rods and cones. In vitro experiments have shown that 
antibodies against recoverin may cause blockage of ion 
channels and cellular depolarization, with eventual 
photoreceptor cell death. When anti-recoverin antibodies 
enter photoreceptor cells, apoptosis occurs without severe 
inflammation [16, 20]. 
  The findings of mild ocular inflammatory cells on 
histopathology in our case are intriguing although not 
unexpected. Macrophages and microglia in the areas of 
 
Fig. (6). Immunofluorescence detection of autoantibody in the patient’s serum on the normal retinal sections. A, no serum incubation 
(control); B, normal human serum incubation (1: 100, control); C, patient’s serum incubation (1: 100); D, higher magnification photo of C. 
There is positive fluorescence in the ganglion cell layer, inner nuclear layer and outer nuclear layer (white arrows) of the normal human 
retinal section incubated with the patient’s serum (Blue fluorescence = nuclear, DAPI staining; green fluorescence = autofluorescence; red 
fluorescence = positive staining). (GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; scale bar indicates 50 μm). Autoimmune Retinopathy in Systemic Lupus Erythematosus  The Open Ophthalmology Journal, 2009, Volume 3    25 
neuronal cell loss (both photoreceptor and optic nerve) 
presumably function to phagocytose the dead neurons and to 
repair tissue damage. Interestingly, scattered T-, but not B-
lymphocytes reflect the ocular pathology at the late stage of 
AIR. It is possible that autoantibodies were produced by 
plasma cells and B-lymphocytes in the lymph node, 
circulated into the eye and attacked the photoreceptors 
without direct ocular infiltration of B-lymphocytes or plasma 
cells. Therefore, general immunosuppresion, in addition to 
therapy targeting B-lymphocytes, such as rituximab, should 
be considered in the management of AIR. 
CONCLUSION 
  This report highlights the ocular histopathological 
features of wide-spread loss of photoreceptor and mild mac-
rophage infiltration and microglia accumulation resulting 
from AIR. These findings may help improve our under-
standing of the pathogenesis of this disease. 
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